We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+1.26%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$6.28B
AUM Growth
-$59.5M
Cap. Flow
-$78.7M
Cap. Flow %
-1.25%
Top 10 Hldgs %
28.49%
Holding
498
New
72
Increased
148
Reduced
175
Closed
71

Sector Composition

Rank Sector Weight
1 Energy 51.06%
2 Financials 8.91%
3 Industrials 7.34%
4 Consumer Discretionary 5.31%
5 Technology 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPMC
276
DELISTED
Blueprint Medicines
BPMC
$1.19M 0.02%
17,065
-10,072
-37% -$538K
NTRA icon
277
Natera
NTRA
$37.7B
$1.19M 0.02%
+92,107
New +$1.02M
SIVB
278
DELISTED
SVB Financial Group
SIVB
$1.18M 0.02%
6,316
+1,357
+27% +$239K
LYV icon
279
Live Nation Entertainment
LYV
$41B
$1.18M 0.02%
27,042
+9,769
+57% +$379K
PTC icon
280
PTC
PTC
$13.5B
$1.17M 0.02%
20,733
-6,681
-24% -$370K
FIVN icon
281
FIVE9
FIVN
$1.75B
$1.16M 0.02%
48,375
-49,768
-51% -$1.08M
BERY
282
DELISTED
Berry Global Group, Inc.
BERY
$1.14M 0.02%
21,922
-8,130
-27% -$425K
ROK icon
283
Rockwell Automation
ROK
$51.3B
$1.14M 0.02%
6,376
-3,985
-38% -$663K
FMI
284
DELISTED
Foundation Medicine, Inc.
FMI
$1.13M 0.02%
+28,131
New +$1.09M
TCF
285
DELISTED
TCF Financial Corporation Common Stock
TCF
$1.12M 0.02%
+21,497
New +$1.03M
PEN icon
286
Penumbra
PEN
$12.5B
$1.12M 0.02%
12,429
-15,117
-55% -$1.3M
NKTR icon
287
Nektar Therapeutics
NKTR
$2.42B
$1.12M 0.02%
3,099
-604
-16% -$189K
PKX icon
288
POSCO
PKX
$15.9B
$1.11M 0.02%
+16,017
New +$1.15M
GAP
289
The Gap Inc
GAP
$6.8B
$1.1M 0.02%
+37,239
New +$915K
BX icon
290
Blackstone
BX
$101B
$1.1M 0.02%
32,843
-7,358
-18% -$242K
APTV icon
291
Aptiv
APTV
$11.9B
$1.08M 0.02%
11,006
-1,557
-12% -$147K
MSGS icon
292
Madison Square Garden
MSGS
$9.6B
$1.08M 0.02%
7,058
+2,451
+53% +$371K
URI icon
293
United Rentals
URI
$70.3B
$1.08M 0.02%
7,757
+1,779
+30% +$213K
ROP icon
294
Roper Technologies
ROP
$36.3B
$1.07M 0.02%
4,387
-1,059
-19% -$249K
SYY icon
295
Sysco
SYY
$39.7B
$1.06M 0.02%
19,575
-238,351
-92% -$12.4M
PHM icon
296
Pultegroup
PHM
$24.1B
$1.05M 0.02%
38,581
-9,895
-20% -$250K
CGNX icon
297
Cognex
CGNX
$10.4B
$1.05M 0.02%
19,014
-3,540
-16% -$180K
COR
298
DELISTED
Coresite Realty Corporation
COR
$1.03M 0.02%
9,212
-27,807
-75% -$3.06M
RJF icon
299
Raymond James Financial
RJF
$32.2B
$1.02M 0.02%
18,191
-1,876
-9% -$101K
BBVA icon
300
Banco Bilbao Vizcaya Argentaria
BBVA
$143B
$1.01M 0.02%
113,720
+69,335
+156% +$614K

Similar funds

Advisory Research's Q3 2017 Portfolio in Review

As of Q3 2017, Advisory Research held 498 positions worth $6.28B, down 0.94% from $6.34B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Advisory Research's Q3 2017 filing shows 72 new, 148 increased, 175 reduced and 71 closed positions. Its largest new stake was Anadarko Petroleum Corporation: 1,567,067 shares worth $62.1M. The largest sale was Oneok Partners LP, an estimated $55.7M.

By sector, the portfolio is most concentrated in Energy at 51% of assets, down from 53% a quarter earlier, followed by Financials and Industrials.

  • Advisory Research's largest Q3 2017 buy was Anadarko Petroleum Corporation: 1,567,067 shares worth $62.1M.
  • Advisory Research added most to Oneok in Q3 2017, an estimated $34.1M increase.
  • Advisory Research's biggest Q3 2017 reduction was Brink's, cutting an estimated $32M.
  • Advisory Research fully exited Oneok Partners LP in Q3 2017, selling an estimated $55.7M.
  • Advisory Research's ten largest holdings make up 28% of its $6.28B portfolio in Q3 2017.
  • Advisory Research opened 72 new positions and closed 71 in Q3 2017.
  • Advisory Research's portfolio value fell 0.94% quarter-over-quarter to $6.28B.

Based on Advisory Research's 13F filing for Q3 2017, filed 14 Nov 2017.